Modernization of Cosmetics Regulation Act of 2022
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023.
Among the Act’s many provisions is the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which significantly expands the US Food and Drug Administration’s (FDA) regulation of cosmetic products in the United States. The MoCRA amends the Federal Food, Drug, and Cosmetic Act (FDCA) and imposes extensive new requirements related to cosmetic products, as described in the white paper linked below.
Notably, FDA will spend the next two years developing certain implementing regulations as required by the MoCRA. This will offer stakeholders multiple chances to influence the nature of these rules, both before and after a proposed rule is published.
If you are interested in more information about the MoCRA or would like guidance on complying with these new requirements, please contact ArentFox Schiff’s FDA Practice Group.
